Contineum Therapeutics, Inc. ($CTNM)
Filing Information
| Accession Number | 0001628280-26-047909 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 10, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
3,120
Total Value
$17,690.40
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Class A Common Stock | โ | Jul 8, 2026 | Exercise/Conversion | 1,015 | $1.01 | $1,025.15 | 136,217 | Direct | โ | View Details | |
Chief Scientific Officer | Class A Common Stock | โ | Jul 8, 2026 | Sale | 1,015 | $16.00 | $16,240.00 | 135,202 | Direct | โ | View Details | |
Chief Scientific Officer | Class A Common Stock | โ | Jul 9, 2026 | Exercise/Conversion | 25 | $1.01 | $25.25 | 135,227 | Direct | โ | View Details | |
Chief Scientific Officer | Class A Common Stock | โ | Jul 9, 2026 | Sale | 25 | $16.00 | $400.00 | 135,202 | Direct | โ | View Details | |
Chief Scientific Officer | Stock Option (right to buy) | Derivative | Jul 8, 2026 | Exercise/Conversion | 1,015 | $0.00 | $0.00 | 33,282 | Direct | โ | View Details | |
Chief Scientific Officer | Stock Option (right to buy) | Derivative | Jul 9, 2026 | Exercise/Conversion | 25 | $0.00 | $0.00 | 33,257 | Direct | โ | View Details |